Possible therapeutic targets for SARS-CoV-2 infection and COVID-19
- PMID: 37564275
- PMCID: PMC10414779
- DOI: 10.46439/allergy.2.028
Possible therapeutic targets for SARS-CoV-2 infection and COVID-19
Abstract
SARS-CoV-2 infection causes COVID-19, which has emerged as a health emergency worldwide. SARS-CoV-2 infects cells by binding to ACE2 receptors and enters into the cytoplasm following its escape from endolysosomes. Once in the cytoplasm, the virus replicates and eventually causes various pathological conditions including acute respiratory distress syndrome (ARDS) that is caused by pro-inflammatory cytokine storms. Thus, endolysosomes and cytokine storms are important therapeutic targets to suppress SARS-CoV-2 infection and COVID-19. Here, we discuss therapeutic targets of SARS-CoV-2 infection and available drugs that could be helpful in the suppression of the SARS-CoV-2 infection and pathological condition COVID-19. The urgency of the COVID-19 pandemic precludes the development of new drugs and increased focus on drug repurposing might provide the quickest way to finding effective medicines.
Keywords: ARDS (Acute Respiratory Distress Syndrome); COVID-19 (Coronavirus Infectious Disease-19); Cytokine Storm; Endolysosomes; SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2).
Conflict of interest statement
Conflict of Interest No Conflict of Interest.
Similar articles
-
Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments.Front Pharmacol. 2020 Oct 29;11:595888. doi: 10.3389/fphar.2020.595888. eCollection 2020. Front Pharmacol. 2020. PMID: 33324224 Free PMC article.
-
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.Rev Recent Clin Trials. 2021;16(2):138-145. doi: 10.2174/1574887115666200917110954. Rev Recent Clin Trials. 2021. PMID: 32940187 Review.
-
Possible Therapeutic Use of Natural Compounds Against COVID-19.J Cell Signal. 2021;2(1):63-79. J Cell Signal. 2021. PMID: 33768214 Free PMC article.
-
Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.Front Immunol. 2021 Apr 28;12:589095. doi: 10.3389/fimmu.2021.589095. eCollection 2021. Front Immunol. 2021. PMID: 33995341 Free PMC article. Review.
-
Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.Life Sci. 2020 Sep 15;257:118102. doi: 10.1016/j.lfs.2020.118102. Epub 2020 Jul 18. Life Sci. 2020. PMID: 32687918 Free PMC article. Review.
References
-
- CoViD-19 (2019-nCoV) Data Repository by Johns Hopkins University Center for Systems Science and Engineering (JHU CSSE). 2020.
-
- Guy RK, DiPaola RS, Romanelli F, Dutch RE. Rapid repurposing of drugs for COVID-19. Science. 2020. May 22;368(6493):829–30. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous